ASCO Adapts CCO Guideline on Selection of Optimal Adjuvant Therapies for HER2-Negative and HER2-Positive Breast Cancers

Sep 12, 2016

Virginia Cancer Specialist's Dr. Dunduluri, is the co-chiar of an expert ASCO panel.

Return to News